Valneva SE, a biotech company developing and commercializing vaccines for infectious diseases, has signed a new $59 million contract with the U.S. government Department of Defense for the supply of its Japanese encephalitis (JE) vaccine Ixiaro.   Valneva will supply Ixiaro doses to the Defense Logistics Agency of the U.S. Department of Defense, through 2019 and the beginning of 2020 with a value of $59 million guaranteed and potentially worth up to $70 million. A delivery schedule is being pr...